Semaglutide, sold under the brand names Wegovy and Ozempic, has helped Novo Nordisk establish a foothold in the market for ...

Novo ​Nordisk's Wegovy weight-loss pill has made an encouraging start after its launch this month, analysts said on Friday ...

The U.K.’s health regulator approved a higher dose of Novo Nordisk’s Wegovy weight-loss drug applicable to patients with a ...

True, Novo Nordisk is making progress in this field. It recently earned approval for an oral formulation of Wegovy, which ...

Novo Nordisk ( NVO +1.68%) was once the top player in the weight loss drug market. The company's medicine, Wegovy, ...

TUESDAY, Jan. 6, 2026 (HealthDay News) — A daily pill for weight loss has officially arrived in the U.S. On Monday, Novo ...

Novo Nordisk executive Dave Moore touted high interest in Wegovy's oral version of its injectable GLP-1 weight-loss ...

Novo Nordisk has launched its first oral GLP-1 weight-loss pill in the United States, expanding beyond injectable treatments ...

Novo Nordisk announced Jan. 5 it will begin offering its Wegovy weight loss pill to self-paying patients in the United States ...

The U.S. Food and Drug Administration on Dec. 22 approved a pill version of Novo Nordisk’s weight-loss drug Wegovy.

Agency officials say a comprehensive review “found no increased risk” related to suicide among users of the GLP-1 drugs used ...